Publications
(2026) Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer. Eur J Med Chem. 311, 118798
NECAT
9700 S. Cass Ave.
Bldg. 436E
Lemont, IL 60439
630.252.0689
csalbego@cornell.edu
Copyright © 2026, NECAT
Design by FreeBiezz
